ANI Pharmaceuticals Q1 EPS $(0.12) Misses $0.09 Estimate, Sales $64.50M Miss $65.03M Estimate
ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.09 by 233.33 percent. This is a 111.54 percent decrease over earnings of $1.04 per share